Ovarian Cancer

There are several major types of ovarian cancer, with epithelial ovarian cancer being the most common, accounting for the majority of cases. Other less common forms include germ cell tumors, which arise from egg-producing cells, and stromal tumors, which develop from hormone-producing tissue within the ovary. Each subtype differs in behavior, treatment response, and prognosis.

Risk factors for ovarian cancer include increasing age, particularly after menopause, inherited genetic mutations such as BRCA1 and BRCA2, and a family history of ovarian, breast, or colorectal cancer. Additional factors include endometriosis, infertility, and never having been pregnant. Conversely, use of oral contraceptives, breastfeeding, and multiple pregnancies are associated with a reduced risk.

Symptoms are often subtle and may be mistaken for common gastrointestinal or urinary conditions. These can include persistent abdominal bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urinary urgency or frequency, and unexplained fatigue. Because these symptoms are non-specific, they are frequently overlooked in early disease stages.

Diagnosis typically involves a combination of pelvic examination, imaging studies such as transvaginal ultrasound or CT scans, and blood tests including CA-125, a tumor marker that may be elevated in some cases. A definitive diagnosis is usually confirmed through surgical exploration and pathological examination of ovarian tissue.

Treatment depends on the stage and type of ovarian cancer but commonly involves a combination of surgery and chemotherapy. Surgical management often includes removal of the ovaries, fallopian tubes, and uterus, along with staging procedures to assess disease spread. Chemotherapy is typically used after surgery, and in some cases, targeted therapies such as PARP inhibitors are used, especially in patients with BRCA mutations.

Advances in medical research have improved survival rates, particularly with the development of personalized medicine approaches that tailor treatment based on genetic and molecular tumor profiles. Clinical trials continue to explore immunotherapy and novel targeted agents, offering hope for more effective and less toxic treatments in the future.

Living with ovarian cancer can be physically and emotionally challenging, requiring ongoing medical care and psychosocial support. Survivorship care may include pain management, nutritional guidance, counseling, and monitoring for recurrence. Early detection remains difficult, but increased awareness of symptoms and risk factors plays a critical role in improving prognosis and supporting patients and families.

Publisher - Xspurts.com

Language - English

Perfect Bound

Contributors

By author

Wyatt U. Sinclair

Published Date - 2026-05-26

ISBN - 9781776830169

Dimensions - 19.7 x 13.2 x 1.1 cm

Page Count - 200